← Research library

Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress

Lab research · 2000

What was studied
Cultured cerebellar granule cells; experimental injury models
Main finding
GVS-111 showed protective effects in oxygen/glucose deprivation and glutamate/oxidative-stress models; piracetam did not attenuate glutamate toxicity in this experiment.

Study data at a glance

Participants or experimental model
Cultured cerebellar granule cells; experimental injury models
Reported results
GVS-111 showed protective effects in oxygen/glucose deprivation and glutamate/oxidative-stress models; piracetam did not attenuate glutamate toxicity in this experiment.
Study limitations and source details

Study limitations

  • Cell survival is not human clinical neuroprotection.
  • The assay-specific piracetam comparison is not a clinical superiority result.

Source details

Indexed primary-paper record and abstract checked; full methods and risk of bias not appraised.

Sources checked

Citation

In vitroEnglish abstract

N. A. Andreeva, E. V. Stel’mashuk, N. K. Isaev, R. U. Ostrovskaya, T. A. Gudasheva, I. V. Viktorov. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress Bull Exp Biol Med. 130(10):969–972

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards